[1]
2022. To Evaluate the Effectiveness of Dpp4 Inhibitors in Relation to Blood Sugar and Lipid Profile. Indian Journal of Public Health Research & Development. 13, 3 (Jun. 2022), 175–179. DOI:https://doi.org/10.37506/ijphrd.v13i3.18192.